Labiotech.eu

News and Trends 1 Jul 2022

Progress for hearing preservation trial after Australian approval granted

Approval has been granted by the Australian authorities to allow a French company to progress with a clinical trial testing cochlear implants. Montpellier-based Sensorion will start its proof of concept trial of SENS-401, a drug candidate that aims to protect and preserve inner ear tissue from damage. Sensorion is a biotech company specializing in the […]

July 1, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

Companies come together in fight against Dengue Fever

A vaccine to treat dengue fever, the mosquito-borne disease, is the end goal of two companies who have signed an agreement to produce and commercialize a lead candidate in the fight against the disease. Emergex Vaccines Holding Limited, a clinical-stage biotech company, recently announced that it has agreed a collaboration with the Molecular Biology Institute […]

July 1, 2022 - 4 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

License submitted to FDA for drug to help those with large B-cell lymphoma

A biologics license application has been submitted to the US Food and Drug Administration (FDA) for an antibody to treat patients with B-cell lymphoma. Genmab A/S is a biotechnology company that says its core purpose is to improve the lives of people with cancer. Recently it announced its intent to submit the application for subcutaneous […]

July 1, 2022 - 3 minutesmins - By Liza Laws

News and Trends 1 Jul 2022

Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever

On this week’s podcast, we have three conversations: with Manfred Rüdiger, CEO of Ariceum Therapeutics; Jon Hague, Unilever’s R&D VP for homecare; and Olivier Rolland, executive director at TWB. Ambrosia and Dionymer winners at 2022 TWB Start-Up Day TWB, which sets up industrial biotechnology R&D projects and designer of innovative and sustainable solutions, announces the […]

July 1, 2022

Continuous cell culture biomanufacturing

In Depth 1 Jul 2022

Continuous cell culture paves the way for better biomanufacturing

The development of continuous cell culture technologies is cutting the costs and resources required for biomanufacturing, benefiting biotech processes ranging from growing cultured meat to manufacturing drugs. The idea of replacing livestock with cell culture to produce meat could reduce animal cruelty, lower greenhouse gas emissions and would require far less land to produce equivalent […]

July 1, 2022 - 6 minutesmins - By Sachin Rawat

News and Trends 1 Jul 2022

FMC dips into pheromone crop protection with $200M BioPhero acquisition

FMC Corporation, an agricultural sciences company, has announced a definitive agreement to acquire BioPhero ApS, a Danish pheromone research and production company. The acquisition adds biologically produced pheromone insect control technology to FMC’s product portfolio and R&D pipeline. BioPhero has pioneered a yeast fermentation process for manufacturing pheromones at lower costs and with fewer production […]

July 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Jul 2022

Symrise Cosmetic Ingredients partners with evoxx technologies

Symrise Cosmetic Ingredients has entered into a strategic partnership with German industrial biotech company evoxx technologies. The companies aim to develop biotechnological processes for ingredients used in beauty applications. The companies said as a result, consumers will be able to purchase beauty products with effective and responsible ingredients. Symrise said consumers today consider the ethical […]

July 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 30 Jun 2022

LG Chem renews license triggering $2M payment to Avacta

South Korean clinical stage biopharmaceutical company, LG Chem Life Sciences, has triggered a license renewal fee to UK-based oncology drug company Avacta Group plc. of $2 million. Avacta develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms. Under the terms of the agreement, LG Chem has the exclusive rights to develop […]

June 30, 2022 - 2 minutesmins - By Liza Laws

News and Trends 30 Jun 2022

NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders

A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule disease-modifying medicines for the treatment for chronic neurogenerative disorders. Domainex, an integrated medicines research services partner has been chosen by neuroscience company, NRG Therapeutics, and will be providing fully integrated lead optimization services including assay biology and medicinal computational chemistry. […]

June 30, 2022 - 3 minutesmins - By Liza Laws

News and Trends 30 Jun 2022

Acticor Biotech gets patent for cardiovascular emergency treatment product

French company Acticor Biotech has announced the European Patent Office (EPO) has granted a new patent that provides protection for the use of Acticor’s product, glenzocimab in thrombotic diseases in Europe until 2036. The grant in Europe complements the ones already obtained in November 2020 in the U.S. and in November 2021 in Singapore, both […]

June 30, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 30 Jun 2022

Evolved By Nature raises $120M for biotech silk technology

Evolved By Nature, the company creating a library of Activated Silk molecules from natural silk protein, has closed $120M in Series C financing. The round was led by Teachers’ Venture Growth (TVG), part of the C$242 billion Ontario Teachers’ Pension Plan Board, and Senator Investment Group, with participation from existing investors including Mousse Partners, Chanel, […]

June 30, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 30 Jun 2022

Funding doubled for company working on breakthrough auto-immune disease therapeutics

A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it has almost doubled its initial funding from two companies. The initial funding for Ermium Therapeutics of €6.3 million ($6.57 million) now stands at €12.3 million ($12.83 million) and has been supplied by Kurma Partners and Fountain Healthcare Partners. Ermium discovers […]

June 30, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Progress for hearing preservation trial after Australian approval granted

Companies come together in fight against Dengue Fever

License submitted to FDA for drug to help those with large B-cell lymphoma

Beyond Biotech podcast 3: Ariceum Therapeutics, TWB, Unilever

Continuous cell culture paves the way for better biomanufacturing

FMC dips into pheromone crop protection with $200M BioPhero acquisition

Symrise Cosmetic Ingredients partners with evoxx technologies

LG Chem renews license triggering $2M payment to Avacta

NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders

Acticor Biotech gets patent for cardiovascular emergency treatment product

Evolved By Nature raises $120M for biotech silk technology

Funding doubled for company working on breakthrough auto-immune disease therapeutics

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!